Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD.
Dahut WL, et al. Among authors: figg wd.
BJU Int. 2013 Jun;111(8):1269-80. doi: 10.1111/j.1464-410X.2012.11667.x. Epub 2013 Feb 18.
BJU Int. 2013.
PMID: 23419134
Free PMC article.
Clinical Trial.